Evidence map›Paper›PMID 26935303›Full record

ArticleNanoscale research letters2016

Effect of Surface Functionalization on the Cellular Uptake and Toxicity of Nanozeolite A.

Sylwia Męczyńska-Wielgosz, Agata Piotrowska, Agnieszka Majkowska-Pilip, Aleksander Bilewicz, Marcin Kruszewski

Abstract read
In one paragraph

Article in Nanoscale research letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Design and Evaluation ofInternational journal of molecular sciences · 2021
    Article
  6. Article
  7. Design and Evaluation ofMaterials (Basel, Switzerland) · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sylwia Męczyńska-WielgoszInstitute of Nuclear Chemistry and Technology, Dorodna 16, Warsaw, 03-195, Poland. s.meczynska@ichtj.waw.pl.
Agata PiotrowskaInstitute of Nuclear Chemistry and Technology, Dorodna 16, Warsaw, 03-195, Poland. a.kasperek@ichtj.waw.pl.
Agnieszka Majkowska-PilipInstitute of Nuclear Chemistry and Technology, Dorodna 16, Warsaw, 03-195, Poland. a.majkowska@ichtj.waw.pl.
Aleksander BilewiczInstitute of Nuclear Chemistry and Technology, Dorodna 16, Warsaw, 03-195, Poland. a.bilewicz@ichtj.waw.pl.
Marcin KruszewskiInstitute of Nuclear Chemistry and Technology, Dorodna 16, Warsaw, 03-195, Poland. m.kruszewski@ichtj.waw.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive use of zeolite nanoparticles in many areas, including medicine, has led to the concern about an impact and possible risk of their use for human health and the environment.In our studies, we investigated an uptake, retention, and cytotoxicity of nanozeolite A (BaA) functionalized with aminopropyl or poly(ethylene glycol) (PEG) of different chain lengths using human cervical carcinoma cell line. For internalization studies, nanozeolite was labeled with (133)Ba radionuclide.The results show that in the case of PEG modification, toxicity and uptake depend on the PEG chain length. The highest toxicity has been observed for nanozeolites coated with short-length chain (Ba-silane-PEGm(MW350). Also, amine-modified nanozeolites exhibited high toxicity, while nanozeolites coated with long PEG molecules, BaA-silane-PEGm(MW1000), and BaA-silane-PEGm(MW2000), as well as unmodified nanozeolite, seem to be nontoxic.In conclusion, this study shows that uptake, retention, and toxicity of nanozeolites coated with various length PEG molecules groups depend on the molecular weight of PEG.

Indexed as

CytotoxicityMetabolic activityNanozeolitePEG functionalization

Identifiers

PMID26935303
PMCPMC4775514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.